A study by Trø seid et al. showed that IL-18 may be an independent marker of the risk of cardiovascular disease in the elderly population with metabolic syndrome by mediating a synergistic pro-inflammatory and hyperglycemic effect [57]. Here, IL18 is linked to cardiovascular disorder.